1. Home
  2. EVER vs OABI Comparison

EVER vs OABI Comparison

Compare EVER & OABI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo EverQuote Inc.

EVER

EverQuote Inc.

N/A

Current Price

$29.10

Market Cap

928.5M

Sector

Technology

ML Signal

N/A

Logo OmniAb Inc.

OABI

OmniAb Inc.

N/A

Current Price

$4.66

Market Cap

773.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
EVER
OABI
Founded
2008
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Programming Data Processing
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
928.5M
773.1M
IPO Year
2018
2021

Fundamental Metrics

Financial Performance
Metric
EVER
OABI
Price
$29.10
$4.66
Analyst Decision
Buy
Strong Buy
Analyst Count
8
7
Target Price
★ $32.33
$8.33
AVG Volume (30 Days)
684.7K
★ 1.3M
Earning Date
11-02-2026
10-30-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 198.86
6.56
EPS
★ 1.53
N/A
Revenue
★ $163,349,000.00
$18,666,000.00
Revenue This Year
$18.77
$94.10
Revenue Next Year
$11.02
$30.33
P/E Ratio
$18.76
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$13.88
$1.35
52 Week High
$31.20
$5.45

Technical Indicators

Market Signals
Indicator
EVER
OABI
Relative Strength Index (RSI) 63.75 42.52
Support Level $22.38 $4.53
Resistance Level $31.20 $5.43
Average True Range (ATR) 1.57 0.32
MACD -0.06 -0.05
Stochastic Oscillator 66.18 4.76

Price Performance

Historical Comparison
EVER
OABI

About EVER EverQuote Inc.

EverQuote Inc operates an online marketplace for insurance shopping, connecting consumers with insurance providers, including carriers and agents. Its marketplace is powered by proprietary data and technology platform that delivers high-intent, pre-validated consumer referrals aligned with insurers underwriting and profitability requirements. The platform provides transparency and campaign management tools, enabling providers to evaluate marketing spend performance and manage return on investment. Consumers can visit insurance provider websites, engage by phone, or submit data to receive quotes. Services are free for consumers, and the company derives revenue principally from consumer inquiries sold as referrals to insurance providers. It derives a majority of revenue from Direct channels.

About OABI OmniAb Inc.

OmniAb Inc licenses discovery research technology to pharmaceutical and biotech companies and academic institutions to enable the discovery of next-generation therapeutics. Its technology platform creates and screens diverse antibody repertoires and is designed to quickly identify optimal antibodies and other target-binding proteins for its partners' drug development efforts. At the heart of the OmniAb platform is what it calls Biological Intelligence, which powers the immune systems of proprietary, engineered transgenic animals to create optimized antibody candidates for human therapeutics.

Share on Social Networks: